Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Jan;146(1):182–188.

Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

R F Caduff 1, C M Johnston 1, T S Frank 1
PMCID: PMC1870768  PMID: 7856726

Abstract

Mutations of the Ki-ras oncogene in endometrial carcinoma have been reported in Japan, but the prevalence and clinical significance of such mutations in the United States remains unclear. DNA extracted from paraffin sections of 112 carcinomas of the endometrium was amplified by the polymerase chain reaction with mismatched primers that generated a BstNI recognition site with the wild-type codon 12. Loss of this recognition site indicating Ki-ras codon 12 mutations was observed in 13 tumors (11.6%), including 11 endometrioid carcinomas, one undifferentiated carcinoma, and one carcinosarcoma. None of 17 papillary serous-clear cell carcinomas contained Ki-ras codon 12 mutations. These mutations were confirmed and characterized by direct sequencing. We found no evidence of correlation of the presence of Ki-ras mutations with stage, grade, depth of invasion, or clinical outcome. Our results indicate that Ki-ras oncogene mutations in carcinoma of the endometrium may be less prevalent in the United States than in Japan.

Full text

PDF
185

Images in this article

184Figure 1
on p.184

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
  2. Bitterman P., Chun B., Kurman R. J. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am J Surg Pathol. 1990 Apr;14(4):317–328. doi: 10.1097/00000478-199004000-00002. [DOI] [PubMed] [Google Scholar]
  3. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  4. Emoto M., Iwasaki H., Kikuchi M., Shirakawa K. Characteristics of cloned cells of mixed müllerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro. Cancer. 1993 May 15;71(10):3065–3075. doi: 10.1002/1097-0142(19930515)71:10<3065::aid-cncr2820711029>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  5. Enomoto T., Fujita M., Inoue M., Rice J. M., Nakajima R., Tanizawa O., Nomura T. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res. 1993 Apr 15;53(8):1883–1888. [PubMed] [Google Scholar]
  6. Enomoto T., Inoue M., Perantoni A. O., Buzard G. S., Miki H., Tanizawa O., Rice J. M. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res. 1991 Oct 1;51(19):5308–5314. [PubMed] [Google Scholar]
  7. Enomoto T., Weghorst C. M., Inoue M., Tanizawa O., Rice J. M. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol. 1991 Oct;139(4):777–785. [PMC free article] [PubMed] [Google Scholar]
  8. Fujimoto I., Shimizu Y., Hirai Y., Chen J. T., Teshima H., Hasumi K., Masubuchi K., Takahashi M. Studies on ras oncogene activation in endometrial carcinoma. Gynecol Oncol. 1993 Feb;48(2):196–202. doi: 10.1006/gyno.1993.1033. [DOI] [PubMed] [Google Scholar]
  9. Hruban R. H., van Mansfeld A. D., Offerhaus G. J., van Weering D. H., Allison D. C., Goodman S. N., Kensler T. W., Bose K. K., Cameron J. L., Bos J. L. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol. 1993 Aug;143(2):545–554. [PMC free article] [PubMed] [Google Scholar]
  10. Ignar-Trowbridge D., Risinger J. I., Dent G. A., Kohler M., Berchuck A., McLachlan J. A., Boyd J. Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol. 1992 Jul;167(1):227–232. doi: 10.1016/s0002-9378(11)91663-9. [DOI] [PubMed] [Google Scholar]
  11. Imamura T., Arima T., Kato H., Miyamoto S., Sasazuki T., Wake N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer. 1992 Apr 22;51(1):47–52. doi: 10.1002/ijc.2910510110. [DOI] [PubMed] [Google Scholar]
  12. Koulos J. P., Wright T. C., Mitchell M. F., Silva E., Atkinson E. N., Richart R. M. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas. Gynecol Oncol. 1993 Mar;48(3):364–369. doi: 10.1006/gyno.1993.1064. [DOI] [PubMed] [Google Scholar]
  13. Lester D. R., Cauchi M. N. Point mutations at codon 12 of C-K-ras in human endometrial carcinomas. Cancer Lett. 1990 May 15;51(1):7–10. doi: 10.1016/0304-3835(90)90223-k. [DOI] [PubMed] [Google Scholar]
  14. Lin S. Y., Chen P. H., Wang C. K., Liu J. D., Siauw C. P., Chen Y. J., Yang M. J., Liu M. H., Chen T. C., Chang J. G. Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol. 1993 Dec;100(6):686–689. doi: 10.1093/ajcp/100.6.686. [DOI] [PubMed] [Google Scholar]
  15. Lynch H. T., Smyrk T. C., Watson P., Lanspa S. J., Lynch J. F., Lynch P. M., Cavalieri R. J., Boland C. R. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993 May;104(5):1535–1549. doi: 10.1016/0016-5085(93)90368-m. [DOI] [PubMed] [Google Scholar]
  16. Mizuuchi H., Nasim S., Kudo R., Silverberg S. G., Greenhouse S., Garrett C. T. Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium. Cancer Res. 1992 May 15;52(10):2777–2781. [PubMed] [Google Scholar]
  17. Parazzini F., La Vecchia C., Bocciolone L., Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol. 1991 Apr;41(1):1–16. doi: 10.1016/0090-8258(91)90246-2. [DOI] [PubMed] [Google Scholar]
  18. Peltomäki P., Lothe R. A., Aaltonen L. A., Pylkkänen L., Nyström-Lahti M., Seruca R., David L., Holm R., Ryberg D., Haugen A. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 1993 Dec 15;53(24):5853–5855. [PubMed] [Google Scholar]
  19. Riou G., Barrois M., Sheng Z. M., Duvillard P., Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene. 1988 Sep;3(3):329–333. [PubMed] [Google Scholar]
  20. Silverberg S. G., Sasano N., Yajima A. Endometrial carcinoma in Miyagi Prefecture, Japan: histopathologic analysis of a cancer registry-based series and comparison with cases in American women. Cancer. 1982 Apr 1;49(7):1504–1510. doi: 10.1002/1097-0142(19820401)49:7<1504::aid-cncr2820490733>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  21. Stokoe D., Macdonald S. G., Cadwallader K., Symons M., Hancock J. F. Activation of Raf as a result of recruitment to the plasma membrane. Science. 1994 Jun 3;264(5164):1463–1467. doi: 10.1126/science.7811320. [DOI] [PubMed] [Google Scholar]
  22. Teneriello M. G., Ebina M., Linnoila R. I., Henry M., Nash J. D., Park R. C., Birrer M. J. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 1993 Jul 1;53(13):3103–3108. [PubMed] [Google Scholar]
  23. Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M., Bos J. L. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525–532. doi: 10.1056/NEJM198809013190901. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES